Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 73 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8900574

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  2. US 8901173

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Jazz Pharmaceuticals, Inc. · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  3. US 8895521

    Methods and compositions for the treatment of uveitis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  4. US 8895018

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    The United States of America as represented by the Department of Veteran Affairs · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  5. US 8895579

    Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases

    Northwestern University · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  6. US 8895539

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  7. US 8889661

    Treatment of lupus nephritis using laquinimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  8. US 8889627

    Treatment of multiple sclerosis with combination of laquinimod and fingolimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  9. US 8883144

    Treatment of pulmonary vascular remodeling with neprilysin

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  10. US 8877188

    Detection and treatment of non-dermal fibrosis

    The Board of Regents of the University of Texas System · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  11. US 8877204

    Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

    University of Connecticut Health Center · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  12. US 8877765

    Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  13. US 8875970

    Structure containing wound treatment material

    Covidien LP · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  14. US 8871925

    Compositions of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  15. US 8865694

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  16. US 8859527

    Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  17. US 8859619

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  18. US 8859585

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  19. US 8853215

    Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

    Takeda Pharmaceutical Company Limited · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  20. US 8852626

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  21. US 8853277

    Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  22. US 8846629

    Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  23. US 8846627

    Method for treatment of malaria

    East China University of Science and Technology · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  24. US 8846770

    Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.